KRTX — Karuna Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $12.58bn
- $11.32bn
- $0.65m
Annual cashflow statement for Karuna Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -44 | -68.6 | -144 | -276 | -434 |
| Depreciation | |||||
| Non-Cash Items | 12.4 | 14.1 | 31.6 | 42.4 | 36.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.599 | -15.6 | 10.8 | 4.77 | 9.53 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -30.9 | -69.9 | -101 | -228 | -386 |
| Capital Expenditures | -0.115 | -0.419 | -3.07 | -0.915 | -2.92 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -174 | -89.2 | -19.6 | -585 | -157 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -174 | -89.7 | -22.7 | -586 | -160 |
| Financing Cash Flow Items | -2.81 | -0.405 | -0.283 | -0.441 | -4.73 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 405 | 3.66 | 278 | 856 | 483 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 200 | -156 | 154 | 41.4 | -62.8 |